Compound
Everything we've written on Thymosin beta-4 — 11 articles covering the mechanism, the evidence, comparisons, and practical considerations.
11 articles
Recovery and inflammationBPC-157 and TB-500 in plain English — what tissue-repair peptides actually doYou tweaked your shoulder in December and by February it still hasn't come back. Not dramatically hurt — just not right. Range of motion down maybe fifteen degrees. A specific ache when you reach behind your back. You've done the PT exercises, you've iced it, you've rested it. The body isn't doing what the body is supposed to do, which is heal. And you start to wonder whether "it'll come back" is actually true.9 min readRecovery and inflammationThe BPC-157 + TB-500 stack — why people pair themIf you spend enough time in the online recovery and performance peptide communities, you start to notice that certain compounds almost never appear alone. BPC-157 and TB-500 are mentioned together so consistently — as a pairing, a protocol, a stack — that newer members sometimes assume they're a single product or that one requires the other. They don't. They're distinct molecules with distinct mechanisms and separate research histories. But the case for combining them, while it has never been directly studied in human clinical trials as a combination, has a mechanistic logic to it that's worth laying out clearly before deciding whether the logic is sufficient.8 min readAnti-aging and cellular healthPeptides for eye and vision health — what research has exploredYou notice it first with menus. The restaurant is dim, you hold the card at arm's length, and still the text swims. Then comes the dry, gritty feeling at the end of a screen-heavy day — the kind that makes you blink repeatedly and wonder whether you've developed an allergy to your own office. For many people moving through midlife, these small functional losses accumulate quietly: the reading glasses on every nightstand, the reduced contrast sensitivity in low light, the occasional floater drifting across the visual field like a slow comma. You mention it at your annual exam and leave with a prescription change. What you rarely get is a conversation about why the aging eye changes the way it does, or whether anything beyond corrective lenses and lubricating drops might be worth knowing about.9 min readAnti-aging and cellular healthPeptides for vision protection — glaucoma, macular degeneration, and dry eyeYou find out you have glaucoma at a routine eye exam. Nothing hurt. Nothing looked different. The visual field test catches a small defect at the periphery, the pressure reading is elevated, the optic nerve has a cup-to-disc ratio that concerns your optometrist enough to send you to an ophthalmologist. The diagnosis is startling not because of what it has done yet but because of what it might do, silently, if the pressure isn't controlled — and because the vision that glaucoma takes doesn't come back. You were not expecting this conversation at 52.9 min readRecovery and inflammationBPC-157 vs TB-500 vs Thymosin Beta-4 vs ARA-290 — the regenerative peptide fieldYou hurt something and it's not getting better. Not dramatically — not torn-tendon surgery territory — but the kind of injury that sits at 60 percent for months, that flares when you push it, that has accumulated enough frustrating physiology-appointments and marginal improvements that you've started looking at the literature yourself. Or maybe it's the gut: a chronically inflamed GI tract that confounds every elimination diet and sits there as a low-grade interference in your life. You've heard that some peptides are researched specifically for tissue repair. You've encountered four names in particular — BPC-157, TB-500, Thymosin Beta-4, ARA-290 — and you want to understand what each actually does before you bring any of them into a clinical conversation.9 min readImmune modulationRheumatoid arthritis and peptides — what regenerative and immune-modulatory research has exploredYou wake up and the first thing you notice is that your hands don't work right yet. It takes twenty minutes, sometimes forty, sometimes longer — this morning stiffness that is different from the ordinary stiffness of sleeping in an awkward position. That one loosens in five minutes. This one is a gripping, syrupy immobility that the joints have to be coaxed through before you can make a fist, open a jar, type. And alongside it, a systemic fatigue that isn't explained by how much you slept. Rheumatoid arthritis is not just a joint disease. The inflammation is systemic — it involves the cardiovascular system, it increases the risk of cardiovascular events, it affects cognition in ways that are only beginning to be characterized. The specific joints are the most visible part, but the whole body is living with what those joints are living with.9 min readRecovery and inflammationTB-500 for athletic recovery and connective tissueThe hamstring has healed — technically. The MRI is clean, the physical therapist signed off, and for about three weeks everything was fine. Then you did one hard sprint and felt it again: not a tear, not acute, just a familiar tightening that settles in above the knee and stays there. This is the second time this year. The trainer calls it a "recurring strain pattern." You've started modifying your training around it, which is its own kind of problem, because now the hip flexor on the same side is angry from compensating, and the whole kinetic chain is beginning to feel like a liability. This is the specific frustration that drives people toward research peptides — not the dramatic single injury but the grinding accumulation of connective tissue problems that never fully resolve, that come back predictably, that conventional sports medicine addresses but doesn't quite fix.8 min readRecovery and inflammationWhat people are reporting about TB-500This article summarizes experiences reported in public online communities including Reddit, longevity forums, and discussion boards. We are not advocating human use of any compound discussed here. Many of the peptides discussed are not FDA-approved for the uses described, and some are explicitly not approved for human or veterinary use. What follows is a synthesis of what people have reported, presented to give readers context on the public conversation — not as guidance, not as evidence of safety or efficacy, and not as a recommendation. Decisions about any compound should be made with a qualified prescribing provider after a full medical evaluation.8 min readRecovery and inflammationTB-500 vs Thymosin Beta-4 — when a fragment isn't the whole moleculeYou ordered it from a research peptide supplier, the vial arrived, and you reconstituted it with bacteriostatic water the way the forum posts told you to. The label says TB-500. The studies you found online say Thymosin Beta-4. You've been assuming, reasonably enough, that these are the same thing — maybe the same thing with two names, the way ibuprofen and Advil are the same thing. They are not quite the same thing. The difference between them is worth understanding before you go any further, not because it invalidates the research, but because it changes what the research actually says about what you're holding.8 min readImmune modulationThe dry eyes that arrived alongside everything elseBy mid-morning, there's a grittiness you can't blink away. It's been there since the first hour at your desk — the screen that used to be fine is now something you're working against, the eyes that used to close comfortably behind contact lenses now ache by noon. At the end of the day your vision blurs slightly when you look up from the computer, and you've started keeping artificial tears in your bag the way other people keep lip balm. You've had the same job, the same screens, the same routine for years. The eyes are new.8 min readRecovery and inflammationThymosin Beta-4 in cardiac recovery researchIn the minutes after a heart attack, something begins that medicine has spent decades trying to redirect. The blocked artery is the event; the aftermath is the problem. Cardiomyocytes — the cells that actually contract to pump blood — begin to die from ischemia, and unlike liver cells or skin cells or the lining of the gut, adult cardiomyocytes don't meaningfully regenerate. The cells that die are replaced, over weeks and months, not with new muscle but with fibrotic scar tissue. The scar doesn't contract. It stiffens the wall. The remaining healthy myocardium compensates, overworks, and in many patients the heart slowly remodels itself into a less efficient shape, a process that underlies the transition from heart attack to heart failure. Modern cardiology is very good at keeping people alive through the initial event. What it has not solved is what comes after.8 min read